Anxiety medication abuse on rise among American adolescents: Study

Image
ANI
Last Updated : Dec 17 2019 | 9:50 PM IST

A recent study by a group of American researchers has pointed towards the worrying trend of rapidly increasing benzodiazepines overdose among American youths over the previous decade.

Benzodiazepines often prescribed to treat anxiety have a considerably high addiction and abuse potential.

The Rutgers University study published in the journal of Clinical Toxicology in which researchers from various institutions have referred to the National Poison Data System and took a sample size of 296,838 instances of benzodiazepine exposure among children below the age of 18.

While the number of cases went down for the children younger than the age of six, a significant upward trend was observed for adolescents where the overdose rates per 100,000 children jumped from 17.7 cases in 2000, all the way up to 27.3 in 2015.

In more than half of such cases, teens deliberately consumed dangerous amounts of benzodiazepines for purposes ranging from abuse to suicide attempt.

According to Diane Cannelo, a medical professional from Rutgers University and one of the co-authors of this research, benzodiazepines overdose may not pose a risk to a person's life on its own but the findings reveal that more and more teenagers hooked to this class of drugs have started to indulge in other types of substances.

Things turn ugly when additional drugs are thrown into the mix, which can further intensify the side effects of benzodiazepines to the extent where any recklessness can prove to be fatal.

The problem can be partly attributed to the fact that such medications are readily available and can be obtained on medical prescription with ease.

Moreover, a positive correlation is clearly apparent between the increasing number of prescriptions for benzodiazepines all over the USA in the past 10 years and the reported cases of poisoning involving this drug.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 17 2019 | 9:37 PM IST

Next Story